Lu et al. reported that the expression of Lin28A in GBM was upregulated, and the knockdown of Lin28A suppressed glycolysis and proliferation in glioma cells by indirectly reducing the transcription of PKM2 (pyruvate kinase muscle 2) and GLUT1 [101]. The gene discussed is SLC2A1; the disease is central nervous system cancer.